Pangram has raised $9 million to scale its AI detection software. The startup has also released a new AI text detection model ...

Overview: SQL remains the most important language for every database administrator.Python simplifies automation, reporting, and database management tasks.Learni ...

We've tested the top AI image generation apps to help you find the one that produces the best results for the lowest price. I’ve been writing about consumer technology and video games for more than a ...

Kualitee, an AI-powered test management platform built by quality engineering firm Kualitatem, announced the launch of Hootie Copilot on June 8, 2026, a new AI feature that generates automation ...

AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...

Director Destin Daniel Cretton, stars Tom Holland and Zendaya, and crew members offer an annotated script from the Sony/Marvel release.

According to @pictoryai on X, Pictory’s AI script generator converts a simple prompt into structured, ready‑to‑edit video scripts within seconds, accelerating the workflow from concept to content ...

EaseMate AI offers an advanced yet easy-to-use AI video creator that helps you turn text prompts, images, or short scripts into high-quality videos. It combines text-to-video, image-to-video, and AI ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...